If you cant get clear, evidence-based answers, dont inject it
Hospital-backed health systems are expanding GLP-1 use to treat chronic kidney disease, cardiovascular complications, and non-alcoholic steatohepatitis (NASH), as per Morgan Stanley
Its being discussed by FDA is not a substitute for data
When people refer to injecting peptides in the stomach, they are typically talking about the fatty tissue around the abdominal area rather than injecting into the stomach itself
Seeking to amend the federal Food, Drug, and Cosmetic Act (FDCA), the bills sponsors frame the proposed legislation as essential to protect patients from untested, unapproved, and potentially dangerous mass compounded drugs. The bill was immediately referred to the House Committee on Energy and Commerce
Starting at 1mg because 'nothing happened' after the first injection reflects a misunderstanding of mechanism